Suppr超能文献

相似文献

1
Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway.
FASEB J. 2012 May;26(5):2187-96. doi: 10.1096/fj.11-199067. Epub 2012 Feb 13.
2
Role of BMP7 in appetite regulation, adipogenesis, and energy expenditure.
Endocrine. 2015 Mar;48(2):405-9. doi: 10.1007/s12020-014-0406-8. Epub 2014 Sep 2.
3
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure.
Nature. 2008 Aug 21;454(7207):1000-4. doi: 10.1038/nature07221.
7
Increased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT1- and CD36-mediated fatty acid uptake.
Antioxid Redox Signal. 2013 Jul 20;19(3):243-57. doi: 10.1089/ars.2012.4536. Epub 2012 Oct 9.
8
Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis.
Mol Cell Biol. 2010 Sep;30(17):4224-33. doi: 10.1128/MCB.00363-10. Epub 2010 Jun 28.
9
Adipocyte-derived extracellular vesicles modulate appetite and weight through mTOR signalling in the hypothalamus.
Acta Physiol (Oxf). 2020 Feb;228(2):e13339. doi: 10.1111/apha.13339. Epub 2019 Jul 27.
10
Hypothalamic mTOR: the rookie energy sensor.
Curr Mol Med. 2014 Jan;14(1):3-21. doi: 10.2174/1566524013666131118103706.

引用本文的文献

4
DNA Methylation in the Hypothalamic Feeding Center and Obesity.
J Obes Metab Syndr. 2023 Dec 30;32(4):303-311. doi: 10.7570/jomes23073. Epub 2023 Dec 21.
5
Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation.
Inflammopharmacology. 2023 Oct;31(5):2161-2172. doi: 10.1007/s10787-023-01321-x. Epub 2023 Aug 25.
7
Progress and obstacles in transplantation of brown adipose tissue or engineered cells with thermogenic potential for metabolic benefits.
Front Endocrinol (Lausanne). 2023 May 16;14:1191278. doi: 10.3389/fendo.2023.1191278. eCollection 2023.
8
Adipokines as Clinically Relevant Therapeutic Targets in Obesity.
Biomedicines. 2023 May 11;11(5):1427. doi: 10.3390/biomedicines11051427.
9
Signaling pathways in obesity: mechanisms and therapeutic interventions.
Signal Transduct Target Ther. 2022 Aug 28;7(1):298. doi: 10.1038/s41392-022-01149-x.

本文引用的文献

1
Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency.
Cytokine Growth Factor Rev. 2011 Aug;22(4):221-9. doi: 10.1016/j.cytogfr.2011.08.001. Epub 2011 Sep 15.
2
3
Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.
Cell Metab. 2011 Jul 6;14(1):67-79. doi: 10.1016/j.cmet.2011.04.013.
5
Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage.
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3791-6. doi: 10.1073/pnas.1014715108. Epub 2011 Feb 9.
7
Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.
Endocr Rev. 2011 Jun;32(3):387-403. doi: 10.1210/er.2010-0018. Epub 2010 Dec 20.
8
Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat.
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):143-8. doi: 10.1073/pnas.1010929108. Epub 2010 Dec 20.
10
Melanocortin-4 receptor activation promotes insulin-stimulated mTOR signaling.
Peptides. 2010 Oct;31(10):1888-93. doi: 10.1016/j.peptides.2010.06.028. Epub 2010 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验